Arthur Butcher Biography and Net Worth

Director of STAAR Surgical


Mr. Butcher currently serves as Executive Vice President and Group President, MedSurg and Asia Pacific for Boston Scientific, a position he has held since May 2022. Prior to his current role, Mr. Butcher served as Boston Scientific’s Executive Vice President and President, Asia Pacific, from February 2020 to May 2022, and was responsible for commercialization of the company’s full portfolio of products across all divisions in the Asia Pacific region. Mr. Butcher joined Boston Scientific in 1997, and he has held management roles with increasing responsibility and has deep experience across the company’s divisions. He currently serves as a member of the Board of Directors of Acotec Scientific Holdings Limited, listed publicly on the Hong Kong Stock Exchange. Mr. Butcher received a B.A. in International Relations from the University of Pennsylvania and an M.B.A. from Columbia University.  

What is Arthur C. Butcher's net worth?

The estimated net worth of Arthur C. Butcher is at least $627.76 thousand as of December 1st, 2025. Mr. Butcher owns 23,600 shares of STAAR Surgical stock worth more than $627,760 as of December 4th. This net worth evaluation does not reflect any other assets that Mr. Butcher may own. Learn More about Arthur C. Butcher's net worth.

How do I contact Arthur C. Butcher?

The corporate mailing address for Mr. Butcher and other STAAR Surgical executives is 25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA, 92630. STAAR Surgical can also be reached via phone at (626) 303-7902 and via email at [email protected]. Learn More on Arthur C. Butcher's contact information.

Has Arthur C. Butcher been buying or selling shares of STAAR Surgical?

Arthur C. Butcher has not been actively trading shares of STAAR Surgical over the course of the past ninety days. Most recently, on Monday, August 12th, Arthur C. Butcher bought 1,315 shares of STAAR Surgical stock. The stock was acquired at an average cost of $37.99 per share, with a total value of $49,956.85. Following the completion of the transaction, the director now directly owns 4,208 shares of the company's stock, valued at $159,861.92. Learn More on Arthur C. Butcher's trading history.

Who are STAAR Surgical's active insiders?

STAAR Surgical's insider roster includes Hans-Martin Blickensdoerfer (VP), Arthur Butcher (Director), James Francese (VP), Samuel Gesten (Insider), Graydon Hansen (VP), Jon Hayashida (VP), Keith Holliday (CTO), Elizabeth Lin (Director), Caren Mason (CEO), Aimee Weisner (Director), and Patrick Williams (CFO). Learn More on STAAR Surgical's active insiders.

Are insiders buying or selling shares of STAAR Surgical?

During the last twelve months, STAAR Surgical insiders bought shares 20 times. They purchased a total of 3,348,457 shares worth more than $71,956,325.93. The most recent insider tranaction occured on November, 21st when Major Shareholder Broadwood Partners, L.P. bought 797,486 shares worth more than $22,217,959.96. Insiders at STAAR Surgical own 0.6% of the company. Learn More about insider trades at STAAR Surgical.

Information on this page was last updated on 11/21/2025.

Arthur C. Butcher Insider Trading History at STAAR Surgical

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/12/2024Buy1,315$37.99$49,956.854,208View SEC Filing Icon  
See Full Table

Arthur C. Butcher Buying and Selling Activity at STAAR Surgical

This chart shows Arthur C Butcher's buying and selling at STAAR Surgical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

STAAR Surgical Company Overview

STAAR Surgical logo
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
Read More

Today's Range

Now: $26.60
Low: $26.18
High: $26.93

50 Day Range

MA: $26.41
Low: $24.26
High: $28.00

2 Week Range

Now: $26.60
Low: $13.50
High: $30.81

Volume

604,368 shs

Average Volume

744,695 shs

Market Capitalization

$1.32 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.01